Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays

被引:54
作者
Gasparri, Fabio [3 ]
Wang, Naining [2 ]
Skog, Sven [2 ]
Galvani, Arturo [3 ]
Eriksson, Staffan [1 ]
机构
[1] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, S-75123 Uppsala, Sweden
[2] Karolinska Univ Hosp, Dept Oncol, S-14186 Huddinge, Sweden
[3] Nerviano Med Sci, Dept Biol, Nerviano, Italy
基金
瑞典研究理事会;
关键词
Cell cycle; Biomarkers; Thymidine kinase; G1; cells; Monoclonal antibodies; Immunofluorescence; NON-HODGKINS-LYMPHOMA; MARKER; PROLIFERATION; DEGRADATION; PEPTIDE; MITOSIS; GENE;
D O I
10.1016/j.ejcb.2009.06.005
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Thymidine kinase 1 (TK1) is a DNA salvage enzyme involved in the synthesis of thymidine triphosphate needed during S phase. Although TK1 has been utilized as a cell proliferation marker for many years no well-characterized antibodies are available. The preparation and properties of two types of poly- and monoclonal anti-TK1 peptide antibodies are described and they are used to determine the levels of TK1 in intact cells. Expression of TK1, c-fos, cyclin B1, Ki67, phosphorylated histone H3, phosphorylated ribosomal protein S6, as well as bromodeoxyuridine (BrdU) incorporation in human normal dermal fibroblast cultures were studied with high-content ArrayScan (TM) fluorescence microscopy. The levels of TK1 increased 6-7h after serum re-addition to starved cells as they passed through G1, S and G2/M phases, which was earlier than the increase in Ki67 protein levels and before BrdU incorporation was detected. Thus, a population of activated G1 cells with high TK1 and low Ki67 expression could be identified and their role in cell proliferation can now be clarified. (C) 2009 Elsevier GmbH. All rights reserved.
引用
收藏
页码:779 / 785
页数:7
相关论文
共 22 条
[1]
Thymidine kinase as a proliferative marker:: Clinical relevance in 1,692 primary breast cancer patients [J].
Broët, P ;
Romain, S ;
Daver, A ;
Ricolleau, G ;
Quillien, V ;
Rallet, A ;
Asselain, B ;
Martin, PM ;
Spyratos, F .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2778-2787
[2]
Structure and function of cellular deoxyribonucleoside kinases [J].
Eriksson, S ;
Munch-Petersen, B ;
Johansson, K ;
Eklund, H .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (08) :1327-1346
[3]
ERIKSSON S, 2008, Patent No. 2008142664
[4]
SEQUENCE, STRUCTURE AND PROMOTER CHARACTERIZATION OF THE HUMAN THYMIDINE KINASE GENE [J].
FLEMINGTON, E ;
BRADSHAW, HD ;
TRAINADORGE, V ;
SLAGEL, V ;
DEININGER, PL .
GENE, 1987, 52 (2-3) :267-277
[5]
Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScanTM high-content screening reader [J].
Gasparri, F ;
Mariani, M ;
Sola, F ;
Galvani, A .
JOURNAL OF BIOMOLECULAR SCREENING, 2004, 9 (03) :232-243
[6]
PRODUCTION OF A MOUSE MONOCLONAL-ANTIBODY REACTIVE WITH A HUMAN NUCLEAR ANTIGEN ASSOCIATED WITH CELL-PROLIFERATION [J].
GERDES, J ;
SCHWAB, U ;
LEMKE, H ;
STEIN, H .
INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (01) :13-20
[7]
THE USE OF SERUM DEOXYTHYMIDINE KINASE AS A PROGNOSTIC MARKER, AND IN THE MONITORING OF PATIENTS WITH NON-HODGKINS LYMPHOMA [J].
GRONOWITZ, JS ;
HAGBERG, H ;
KALLANDER, CFR ;
SIMONSSON, B .
BRITISH JOURNAL OF CANCER, 1983, 47 (04) :487-495
[8]
THYMIDINE KINASE - A TUMOR-MARKER WITH PROGNOSTIC VALUE FOR NON-HODGKINS-LYMPHOMA AND A BROAD RANGE OF POTENTIAL CLINICAL-APPLICATIONS [J].
HALLEK, M ;
WANDERS, L ;
STROHMEYER, S ;
EMMERICH, B .
ANNALS OF HEMATOLOGY, 1992, 65 (01) :1-5
[9]
He QM, 1996, EUR J CELL BIOL, V70, P117
[10]
HENGSTSCHLAGER M, 1994, J BIOL CHEM, V269, P13836